Starling Oncology, Inc. (STLN)

NASDAQ: STLN · Real-Time Price · USD

5.17

+0.04 (0.78%)

At close: Aug 4, 2026, 4:00 PM EDT

5.22

+0.05 (0.97%)

After-hours: Aug 4, 2026, 7:31 PM EDT

Starling Oncology Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	545.76	502.73	393.41	324.24	252.48	203
Revenue Growth	35.37%	27.79%	21.33%	28.42%	24.37%	8.26%
Gross Profit	82.5	76.44	54	59.57	52.09	40.85
Operating Income	-32.69	-36.08	-60.12	-60.15	-72.01	-45.38
Net Income	-36.32	-50.31	-53.01	-67.88	0.07	-10.63
Earnings Per Share	-0.37	-0.54	-0.71	-0.92	-0.21	-0.16
EPS Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Patient Services	235.01	228.99	204.88	213.5	166.79	124.07
Specialty Pharmacy	307.42	269.18	179.92	103.84	79.34	72.55
Clinical Trials & Other	3.33	4.56	8.61	6.9	6.36	6.38
Total	545.76	502.73	393.41	324.24	252.48	203

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	30.28	33.57	49.67	82.86	73.81	114.3
Total Debt	104.91	103.75	123.15	119.68	108.18	0.18
Net Cash (Debt)	-74.63	-70.19	-73.48	-36.82	-34.37	114.12
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.76	-0.76	-0.98	-0.50	-0.43	1.72

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-21.81	-24.59	-26.54	-36.32	-61.76	-32.68
Capital Expenditures	-3.91	-3.2	-3.79	-4.57	-5.53	-2.85
Free Cash Flow	-25.73	-27.79	-30.33	-40.88	-67.29	-35.53
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	15.12%	15.20%	13.73%	18.37%	20.63%	20.12%
Operating Margin	-5.99%	-7.18%	-15.28%	-18.55%	-28.52%	-22.36%
Pretax Margin	-8.00%	-12.08%	-16.44%	-25.63%	-0.04%	-5.71%
Profit Margin	-6.66%	-10.01%	-13.47%	-20.93%	0.03%	-5.24%
FCF Margin	-4.71%	-5.53%	-7.71%	-12.61%	-26.65%	-17.50%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	1805.81	-
PS Ratio	0.96	0.70	0.06	0.46	0.49	3.52